Published in PLoS Negl Trop Dis on January 13, 2009
Defining research to improve health systems. PLoS Med (2010) 2.92
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. Genome Res (2011) 2.21
Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and Nepal. Am J Trop Med Hyg (2010) 1.74
Effect of village-wide use of long-lasting insecticidal nets on visceral Leishmaniasis vectors in India and Nepal: a cluster randomized trial. PLoS Negl Trop Dis (2010) 1.61
The neglected tropical diseases of India and South Asia: review of their prevalence, distribution, and control or elimination. PLoS Negl Trop Dis (2011) 1.52
Enhanced case detection and improved diagnosis of PKDL in a Kala-azar-endemic area of Bangladesh. PLoS Negl Trop Dis (2010) 1.51
Insecticide susceptibility of Phlebotomus argentipes in visceral leishmaniasis endemic districts in India and Nepal. PLoS Negl Trop Dis (2010) 1.50
Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs. PLoS Negl Trop Dis (2011) 1.42
The Indian and Nepalese programmes of indoor residual spraying for the elimination of visceral leishmaniasis: performance and effectiveness. Ann Trop Med Parasitol (2011) 1.37
Evaluation of rK-39 strip test using urine for diagnosis of visceral leishmaniasis in an endemic region of India. Am J Trop Med Hyg (2012) 1.09
Development of a reverse transcriptase loop-mediated isothermal amplification (LAMP) assay for the sensitive detection of Leishmania parasites in clinical samples. Am J Trop Med Hyg (2010) 1.07
Report of the Post Kala-azar Dermal Leishmaniasis (PKDL) Consortium Meeting, New Delhi, India, 27-29 June 2012. Parasit Vectors (2013) 1.05
Active case detection in national visceral leishmaniasis elimination programs in Bangladesh, India, and Nepal: feasibility, performance and costs. BMC Public Health (2012) 1.04
Post-kala-azar dermal leishmaniasis in Nepal: a retrospective cohort study (2000-2010). PLoS Negl Trop Dis (2011) 1.01
Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent? PLoS Negl Trop Dis (2011) 0.96
The household costs of visceral leishmaniasis care in south-eastern Nepal. PLoS Negl Trop Dis (2013) 0.92
Global aspirations, local realities: the role of social science research in controlling neglected tropical diseases. Infect Dis Poverty (2014) 0.91
Case series of misdiagnosis with rK39 strip test in Indian leishmaniasis. Am J Trop Med Hyg (2011) 0.88
Risk factors for visceral leishmaniasis and asymptomatic Leishmania donovani infection in India and Nepal. PLoS One (2014) 0.87
Risk factors of visceral leishmaniasis: a case control study in north-western Ethiopia. Parasit Vectors (2014) 0.87
Visceral leishmaniasis diagnosis and reporting delays as an obstacle to timely response actions in Nepal and India. BMC Infect Dis (2015) 0.84
Clinical Features and Laboratory Findings of Visceral Leishmaniasis in Children Referred To Children Medical Center Hospital, Tehran, Iran during 2004-2011. Iran J Parasitol (2014) 0.84
Village health workers in Bihar, India: an untapped resource in the struggle against kala-azar. Trop Med Int Health (2012) 0.84
Quantification of the natural history of visceral leishmaniasis and consequences for control. Parasit Vectors (2015) 0.84
Endemic characteristics of infantile visceral leishmaniasis in the People's Republic of China. Parasit Vectors (2013) 0.83
Visceral leishmaniasis clinical management in endemic districts of India, Nepal, and bangladesh. J Trop Med (2012) 0.83
Visceral leishmaniasis-associated mortality in Bangladesh: a retrospective cross-sectional study. BMJ Open (2014) 0.83
Knowledge, attitudes and practices related to visceral leishmaniasis in rural communities of Amhara State: a longitudinal study in northwest Ethiopia. PLoS Negl Trop Dis (2014) 0.82
Social and Economic Burden of Human Leishmaniasis. Am J Trop Med Hyg (2016) 0.82
Monitoring drug effectiveness in kala-azar in Bihar, India: cost and feasibility of periodic random surveys vs. a health service-based reporting system. Trop Med Int Health (2011) 0.81
Epidemiologic Correlates of Mortality among Symptomatic Visceral Leishmaniasis Cases: Findings from Situation Assessment in High Endemic Foci in India. PLoS Negl Trop Dis (2016) 0.78
Kala-azar in pregnancy in Mymensingh, Bangladesh: a social autopsy. PLoS Negl Trop Dis (2014) 0.77
Accelerated active case detection of visceral leishmaniasis patients in endemic villages of Bangladesh. PLoS One (2014) 0.76
How do health care providers deal with kala-azar in the Indian subcontinent? Indian J Med Res (2011) 0.75
Feasibility of a combined camp approach for vector control together with active case detection of visceral leishmaniasis, post kala-azar dermal leishmaniasis, tuberculosis, leprosy and malaria in Bangladesh, India and Nepal: an exploratory study. Trans R Soc Trop Med Hyg (2015) 0.75
Mobile suitcase laboratory for rapid detection of Leishmania donovani using recombinase polymerase amplification assay. Parasit Vectors (2016) 0.75
Real-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of Visceral Leishmaniasis patients and the monitoring of their response to treatment. PLoS One (2017) 0.75
Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum. Parasitol Res (2015) 0.75
Challenges in modeling complexity of neglected tropical diseases: a review of dynamics of visceral leishmaniasis in resource limited settings. Emerg Themes Epidemiol (2017) 0.75
Leishmaniasis. Public health aspects and control. Clin Dermatol (1997) 4.77
Injectable paromomycin for Visceral leishmaniasis in India. N Engl J Med (2007) 3.74
Rapid accurate field diagnosis of Indian visceral leishmaniasis. Lancet (1998) 3.55
A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis. BMJ (2006) 3.11
Can visceral leishmaniasis be eliminated from Asia? J Vector Borne Dis (2008) 2.84
Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis. J Infect Dis (2007) 2.74
Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India. Trop Med Int Health (2006) 2.69
The epidemiology of visceral leishmaniasis in Bangladesh: prospects for improved control. Indian J Med Res (2006) 2.17
Comparative evaluation of parasitology and serological tests in the diagnosis of visceral leishmaniasis in India: a phase III diagnostic accuracy study. Trop Med Int Health (2007) 1.77
Serological diagnosis of Indian visceral leishmaniasis: direct agglutination test versus rK39 strip test. Trans R Soc Trop Med Hyg (2005) 1.75
Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal--the challenges for diagnosis and treatment. Trop Med Int Health (2008) 1.59
Present situation of vector-control management in Bangladesh: a wake up call. Health Policy (2008) 1.54
Immunochromatographic strip-test detection of anti-K39 antibody in Indian visceral leishmaniasis. Ann Trop Med Parasitol (2002) 1.54
Availability of miltefosine for the treatment of kala-azar in India. Bull World Health Organ (2005) 1.53
The economic burden of visceral leishmaniasis for households in Nepal. Trans R Soc Trop Med Hyg (2006) 1.41
Knowledge, attitude, and practices related to Kala-azar in a rural area of Bihar state, India. Am J Trop Med Hyg (2006) 1.40
The economic impact of visceral leishmaniasis on households in Bangladesh. Trop Med Int Health (2006) 1.34
Oral miltefosine for the treatment of Indian visceral leishmaniasis. Trans R Soc Trop Med Hyg (2006) 1.30
Elimination of visceral leishmaniasis in Nepal: pipe-dreams and possibilities. Kathmandu Univ Med J (KUMJ) (2008) 1.14
The economic burden of Kala-azar in households of the Danusha and Mahottari districts of Nepal. Acta Trop (2003) 1.03
Dengue: a continuing global threat. Nat Rev Microbiol (2010) 9.96
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol (2007) 7.36
Drug resistance in leishmaniasis. Clin Microbiol Rev (2006) 7.35
Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis (2002) 7.17
Patterns of auxin transport and gene expression during primordium development revealed by live imaging of the Arabidopsis inflorescence meristem. Curr Biol (2005) 6.35
Imaging plant growth in 4D: robust tissue reconstruction and lineaging at cell resolution. Nat Methods (2010) 4.47
Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance. Clin Infect Dis (2013) 4.03
A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis. BMJ (2006) 3.11
Eco-bio-social determinants of dengue vector breeding: a multicountry study in urban and periurban Asia. Bull World Health Organ (2010) 2.81
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial. Lancet (2011) 2.81
Classifying dengue: a review of the difficulties in using the WHO case classification for dengue haemorrhagic fever. Trop Med Int Health (2006) 2.75
Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. J Exp Med (2007) 2.75
The auxin signalling network translates dynamic input into robust patterning at the shoot apex. Mol Syst Biol (2011) 2.74
Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis. J Infect Dis (2007) 2.74
Multicentre prospective study on dengue classification in four South-east Asian and three Latin American countries. Trop Med Int Health (2011) 2.60
Control of visceral leishmaniasis in latin america-a systematic review. PLoS Negl Trop Dis (2010) 2.50
Triosephosphate isomerase gene characterization and potential zoonotic transmission of Giardia duodenalis. Emerg Infect Dis (2003) 2.46
Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis. PLoS Negl Trop Dis (2010) 2.33
Leishmaniasis: new approaches to disease control. BMJ (2003) 2.30
Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial. BMJ (2010) 2.30
Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Trop Med Int Health (2008) 2.28
Spread of vector-borne diseases and neglect of Leishmaniasis, Europe. Emerg Infect Dis (2008) 2.24
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. Genome Res (2011) 2.21
Visceral leishmaniasis: elimination with existing interventions. Lancet Infect Dis (2011) 2.19
Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clin Infect Dis (2006) 2.17
High incidence of zidovudine induced anaemia in HIV infected patients in eastern India. Indian J Med Res (2010) 2.11
Recurrence in tuberculosis: relapse or reinfection? Lancet Infect Dis (2003) 2.11
SBSPKS: structure based sequence analysis of polyketide synthases. Nucleic Acids Res (2010) 2.09
Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004. Lancet Infect Dis (2005) 2.06
What does dengue disease surveillance contribute to predicting and detecting outbreaks and describing trends? Trop Med Int Health (2008) 2.04
Usefulness and applicability of the revised dengue case classification by disease: multi-centre study in 18 countries. BMC Infect Dis (2011) 2.03
Pattern formation during de novo assembly of the Arabidopsis shoot meristem. Development (2007) 2.02
Dengue vector-control services: how do they work? A systematic literature review and country case studies. Trans R Soc Trop Med Hyg (2010) 2.01
Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use. Clin Infect Dis (2012) 2.00
Acid-fast bacilli culture positivity and drug resistance in abdominal tuberculosis in Mumbai, India. Indian J Gastroenterol (2014) 2.00
Estimation of under-reporting of visceral leishmaniasis cases in Bihar, India. Am J Trop Med Hyg (2010) 1.98
The homeotic protein AGAMOUS controls microsporogenesis by regulation of SPOROCYTELESS. Nature (2004) 1.98
Virgin soil: the spread of visceral leishmaniasis into Uttar Pradesh, India. Am J Trop Med Hyg (2005) 1.96
Combination therapy for visceral leishmaniasis. Lancet Infect Dis (2010) 1.96
Diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg (2010) 1.93
Primary Ewing's sarcoma of cranial bones: analysis of ten patients. Acta Neurochir (Wien) (2011) 1.92
Integrating tuberculosis and HIV care in the primary care setting in South Africa. Trop Med Int Health (2004) 1.89
The effectiveness of active population screening and treatment for sleeping sickness control in the Democratic Republic of Congo. Trop Med Int Health (2004) 1.89
Rapid diagnostic tests for neurological infections in central Africa. Lancet Infect Dis (2013) 1.82
Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin. J Biol Chem (2004) 1.79
Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and Nepal. Am J Trop Med Hyg (2010) 1.74
Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru. Clin Infect Dis (2008) 1.73
Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study. PLoS Negl Trop Dis (2011) 1.67
Diagnostic accuracy of two rK39 antigen-based dipsticks and the formol gel test for rapid diagnosis of visceral leishmaniasis in northeastern Uganda. J Clin Microbiol (2005) 1.67
Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control. PLoS Negl Trop Dis (2011) 1.64
Vector control by insecticide-treated nets in the fight against visceral leishmaniasis in the Indian subcontinent, what is the evidence? Trop Med Int Health (2008) 1.63
Effect of village-wide use of long-lasting insecticidal nets on visceral Leishmaniasis vectors in India and Nepal: a cluster randomized trial. PLoS Negl Trop Dis (2010) 1.61
A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis. Clin Infect Dis (2012) 1.59
Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal--the challenges for diagnosis and treatment. Trop Med Int Health (2008) 1.59
Trypanosomiasis control, Democratic Republic of Congo, 1993-2003. Emerg Infect Dis (2005) 1.58
Comparison of landmark-based and automatic methods for cortical surface registration. Neuroimage (2009) 1.58
Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use. Drug Resist Updat (2006) 1.58
Modular multiantigen T cell epitope-enriched DNA vaccine against human leishmaniasis. Sci Transl Med (2014) 1.57
Endocrine changes in male HIV patients. J Assoc Physicians India (2011) 1.56
Present situation of vector-control management in Bangladesh: a wake up call. Health Policy (2008) 1.54
How to shorten patient follow-up after treatment for Trypanosoma brucei gambiense sleeping sickness. J Infect Dis (2010) 1.53
Multilocus sequence typing and genetic structure of Cryptosporidium hominis from children in Kolkata, India. Infect Genet Evol (2006) 1.52
Drug resistance in leishmaniasis. J Glob Infect Dis (2010) 1.52
Wide geographic distribution of Cryptosporidium bovis and the deer-like genotype in bovines. Vet Parasitol (2006) 1.51
Long-lasting insecticidal nets fail at household level to reduce abundance of sandfly vector Phlebotomus argentipes in treated houses in Bihar (India). Trop Med Int Health (2008) 1.51
Enhanced case detection and improved diagnosis of PKDL in a Kala-azar-endemic area of Bangladesh. PLoS Negl Trop Dis (2010) 1.51
Leishmaniases in the Mediterranean in the era of molecular epidemiology. Trends Parasitol (2008) 1.50
Insecticide susceptibility of Phlebotomus argentipes in visceral leishmaniasis endemic districts in India and Nepal. PLoS Negl Trop Dis (2010) 1.50
Molecular mechanisms of antimony resistance in Leishmania. J Med Microbiol (2007) 1.50
Multilocus microsatellite typing (MLMT) reveals genetic homogeneity of Leishmania donovani strains in the Indian subcontinent. Infect Genet Evol (2008) 1.49